# Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

> **NCT07349498** · — · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 10000 (estimated)

## Conditions studied

- Hematopoietic Stem Cell Transplantation
- Transplant Complication
- Cardiovascular Events

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07349498
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2036-06-30
- **Final completion:** 2036-12-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07349498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07349498, "Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07349498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*